Ausgabe 4/2005
Inhalt (13 Artikel)
Heart failure and statins—Why do we need a clinical trial?
M. Böhm, A. Hjalmarson, J. Kjekshus, U. Laufs, J. McMurray, D. J. van Veldhuisen
The relationship between hospital or operator volume and outcomes of coronary patients undergoing percutaneous coronary interventions
A. Dibra, A. Kastrati, H. Schühlen, A. Schömig
Early time course of neointima formation and vascular remodelling following percutaneous coronary intervention and vascular brachytherapy of in-stent restenotic lesions as assessed by intravascular ultrasound analysis
A. Zimmermann, B. Pöllinger, J. Rieber, A. König, I. Erhard, F. Krötz, H.-Y. Sohn, R. Kantlehner, W. Haimerl, E. Dühmke, M. Leibig, K. Theisen, V. Klauss, T. M. Schiele
N-Terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction
G. Hess, J. Moecks, D. Zdunek
Cardiac risk of coronary patients after reintegration into occupations with heavy physical exertion
R. Wolf, F. Habel, M. Heiermann, R. Jäkel, R. Sinn
Akutes Koronarsyndrom durch Diclofenac induzierte Koronarspasmen
A. Wieckhorst, A. Tiroke, M. Lins, A. Reinecke, G. Herrmann, D. Krüger, R. Simon
Catheter ablation of junctional ectopic tachycardia in children, with preservation of atrioventricular conduction
M. Emmel, N. Sreeram, K. Brockmeier
Positionspapier zur „Automatisierten Externen Defibrillation“
H.-J. Trappe, D. Andresen, H.-R. Arntz, H.-J. Becker, K. Werdan
Qualitätsleitlinien Echokardiographie
W. Fehske, T. Buck, A. Hagendorff, R. S. von Bardeleben, W. Voelker, S. Heinemann